As Table 2 illustrated, T stage, degree of lymph node metastasis, disease stage, and PTPRH expression were considered as high-risk factors, and they were significantly correlated with poor OS of patients with LUAD (P < 0.05). The gene discussed is PTPRH; the disease is metastatic malignant neoplasm in the lymph nodes.